Keywords: sanofi, eloxatin, expanded, indication, received, oxaliplatin, first-line

Sanofi's Eloxatin, Expanded Indication

Article | 07 May 1998

Sanofi has received an expanded indication for Eloxatin(oxaliplatin), for the first-line treatment of metastatic colorectal cancer in combination with ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Drugs

Eloxatin

Oxaliplatin Injection

Go to drug listing